Skip to main content
Download PDF
  • Research article
  • Open access
  • Published:

Measuring motivation for medical treatment: confirming the factor structure of the Achievement Motivation Index for Medical Treatment (AMI-MeT)

BMC Medical Informatics and Decision Making volume 16, Article number: 22 (2016) Cite this article

An Erratum to this article was published on 02 March 2016

Abstract

Background

Developments in chemotherapy have led to changes in cancer care in Japan, with the government promoting a transition to outpatient chemotherapy. This requires patients and their families to participate more actively in treatment than in the past. However, it remains unclear how patients’ motivation for medical treatment affects clinical consultations with their physicians. To investigate this, we developed a psychological index called the Achievement Motive Index for Medical Treatment (AMI-MeT), which comprises self-derived achievement motivation (AMS) and achievement motivation derived from others (AMO). However, its factor structure has not yet been confirmed in populations other than healthy university students. Thus, the aims of this study were to confirm the factor structure of the AMI-MeT in other groups and to determine the convergent and divergent validity of the AMI-MeT.

Methods

The AMI-MeT was administered to university students (n = 414), apparently healthy workers (n = 154), and cancer patients (n = 51). Multi-group confirmatory factor analysis was conducted and the mean scores of the AMI-MeT were compared between the groups. Correlations between the AMI-MeT and the Self-Construal Scale, comprising independent self-construal (IndSC) and interdependent self-construal (InterSC) subscales, were investigated in another group of students (n = 335).

Results

The multi-group confirmatory factor analysis supported a two-factor structure of the AMI-MeT: the weak invariance model was the best fit for the data. The mean scores of the AMI-MeT in apparently healthy workers and cancer patients were significantly higher than that in students (P < .01). The correlation analysis revealed that AMS scores were associated with IndSC scores (r = .25, P < .01) and AMO scores with InterSC scores (r = .30, P < .01).

Conclusion

The two-factor model of the AMI-MeT was deemed appropriate for all three groups, and the subscales of the AMI-MeT successfully reflected the self and other dimensions. The AMI-MeT appears to be an effective tool for measuring medical treatment motivation, making it useful in participant observational research on medical consultations for Japanese cancer treatment.

Peer Review reports

Background

Japan has a history of withholding cancer notification [1], but many surveys have indicated a gradual shift towards disclosing such information [2–7]. Furthermore, developments in chemotherapy have led to changes in cancer care in Japan, and the government has promoted a transition towards outpatient chemotherapy since 2007 [8]. Cancer patients and their families have acknowledged the benefits of outpatient chemotherapy; however, it also requires them to participate more actively in treatment than in the past. Despite much research on Japanese cancer patients’ preferences for receiving bad news [9–11], it remains unclear how patients’ motivation to obtain medical treatment affects clinical consultations with their physicians. To investigate this, we launched the Mixed-methods Observational Research for Informed Consent (MORE-IC) project [12, 13], wherein we performed quantitative and qualitative participant observation of informed consent consultations involving cancer patients. However, this project demanded the availability of a convenient/easily answerable questionnaire for quantifying patients’ interest in medical treatment before starting their consultations. As no such tool exists, we developed a psychological index of patient motivation for treatment, called the Achievement Motive Index for Medical Treatment (AMI-MeT).

Although many patients have been inclined to actively participate in treatment decision making in Japan [2], those who actually can clearly convey their intentions to their physicians remain a relative minority. Physician–patient communication, and the intention underlying patients’ communication about their medical treatment, relates to several factors, such as the social values of the hospital, expectations for medical treatment, preferences for communication style, and so on. Notably, these factors can be interpreted according to the theory of planned behavior [14], as they correspond to the concepts of attitude toward the behavior, subjective norms, and perceived behavior control, which all influence intention. Given that few patients can clearly convey their intentions, we thought it necessary to include the potential interest behind the intention for medical treatment in the concept of motivation for medical treatment. On the other hand, the dualistic concept of achievement motivation in the AMI-MeT was derived from the concepts of self-fulfillment and competition achievement [15], which are analogous to the concepts of self-achievement [16] and ordinal achievement motivation [17, 18], respectively. According to literature on patients’ narratives [19–21], patients often seek to remain themselves during long-term treatment and to create a new identity or continuity of self at the end of life; thus, we supposed that the process of medical decision making can be construed as a form of self-actualization [16] or individuation [22]. To understand how patients view medical treatment, we also referred to the other dualistic concepts of the self and motivation: construals of the self as independent/interdependent [23], and intrinsic/extrinsic motivation [24]. Using these concepts, we holistically defined achievement motivation for medical treatment as a personal interest and value that could exert a potent influence on medical decision making and would be influenced by social norms or expectations.

In an earlier study, we conducted an exploratory factor analysis to derive the subscales of the AMI-MeT, which were as follows: self-derived achievement motivation (AMS), containing 5 items (e.g., “I want to make the best decision for me,” “Even if several therapies are available, I want to find the one that’s preferable for me”); and achievement motivation derived from others (AMO), also containing 5 items (e.g., “It’s important to strive for advanced medical care,” “I want to be treated at a noted hospital”) (Table 1) [25]. The scale items are rated on a 7-point Likert-type scale ranging from 1 (strongly disagree) to 7 (strongly agree). In the previous pilot study, these two subscales had adequate reliability (Cronbach’s alpha = .78–.86), and the construct validity of the AMI-MeT was confirmed through a comparison with Horino’s achievement motive scale [15]. The items of the AMI-MeT were developed in Japanese and translated into English for the present paper (Table 1). As shown in Table 1, the items do not directly represent motivation itself, but indicate a personal interest and value for medical treatment, because of the broad definition of motivation used in this study.

Table 1 A list of items on the Achievement Motive Index for Medical Treatment
Full size table

However, because the AMI-MeT was preliminarily developed in a rather small sample of university students, its reliability and validity remain insufficient. Specifically, the AMI-MeT was tested only using exploratory factor analysis in a single sample of university students; no confirmatory factor analysis has been performed in other populations. Additionally, the AMI-MeT has not yet been applied to the patient population—so far, it can only assess the motivation of university students, who do not have the same needs or interests as do patients. Finally, it remains unclear whether the subscales (AMS and AMO) are in fact based on dualistic concepts of the self, since they have been found to correlate only with achievement for self-fulfillment/competition [15]. These issues indicated the necessity for further investigation of the AMI-MeT among university students as well as other populations.

The aims of this article are, in two studies, to demonstrate that the AMI-MeT data from university students, apparently healthy workers, and cancer patients fit the two-factor model; that AMI-MeT scores differ between the three groups; and that the AMI-MeT subscales correlate with dualistic concepts of the self.

Methods

Ethical considerations

The questionnaire surveys were approved by the institutional review board at Kyoto University Graduate School of Medicine (E-570, E-1107, E-1254, E-1387, and E 1426) and the Kyoto Industrial Health Association (April 2011).

Study 1: investigating the factor structure and the mean scores of the AMI-MeT in multiple groups

To confirm the factor structure of the AMI-MeT in more diverse groups and demonstrate that it accurately assesses motivation for medical treatment, we administered the AMI-MeT to several groups with varying needs for medical treatment: university students, apparently healthy workers, and cancer patients. It is likely that most university students, a young and comparatively healthy population, are less likely to need medicine or to go to the hospital, making them generally less motivated to do. In contrast, cancer patients who have already been diagnosed and informed of their diagnosis might feel a greater need for medical treatment—therefore, they are perhaps a relatively highly motivated population. Workers who had come to a medical institution for a health check were proposed to be a middle population in terms of motivation, somewhere between university students and cancer patients, as they would be potentially aware of the concerns or needs for medical treatment, but not to the same extent as would cancer patients. In other words, given that this group had voluntarily gone for a health screening, they were likely concerned about having undiagnosed diseases or perhaps realized the necessity of obtaining treatment. As such, we defined them as an “apparently healthy” group.

Participants and measure

The first group comprised university students from the Kansai region of Japan, who were asked to complete the questionnaire after a psychology class between October and November 2011. Of the 456 students given the questionnaire, 414 responded to all items of the questionnaire (317 women and 97 men; mean age = 20.8; SD = 5.4); we excluded any answer sheets that contained missing data. The second group comprised apparently healthy workers—that is, workers who had not yet been diagnosed with a disease but who had voluntarily undergone a health screening at a medical institution of the Kyoto Industrial Health Association between April 2011 and March 2012. Two hundred and thirty-three workers received the questionnaire after their health checks at the institution, and 164 completed it; of these, 154 valid responses were obtained (51 women and 103 men; mean age = 46.3; SD = 12.4). The third group comprised patients who had been diagnosed with breast or lung cancer and had come to start chemotherapy at Kyoto University Hospital between January and July 2009 or between April 2012 and January 2013. The questionnaire survey was administered to cancer patients who were part of the MORE-IC project. After the first author explained the aim of the MORE-IC project, 51 valid responses were obtained (32 women and 19 men; mean age = 60.8; SD = 11.6).

Motivation for medical treatment was measured using the AMI-MeT, as described previously.

Analysis 1: multi-group structural equation modeling

To confirm the factor structure of the AMI-MeT in all three groups, we performed a confirmatory factor analysis with maximum likelihood estimation. Specifically, we used structural equation modeling (SEM) with a multi-group procedure [26–28] and compared the model invariance: configural, weak, strong, and complete invariance. Configural invariance is the simplest form of invariance, wherein no constraints are placed on the parameters; it is satisfied if a defined factor structure is a good fit to the data for all groups. Then, weak, strong, and complete forms of invariance were tested in sequence by placing constraints on the parameters (i.e., factor loadings, factor variances/covariance, and error variances) of the configural invariance model [27, 28]. Specifically, testing weak invariance involves constraining the factor loadings to be equal between the groups; when weak invariance is satisfied (i.e., the model is a good fit), the latent variables being measured are the same across the groups. Testing strong invariance involves placing equality constraints on both the factor loadings and the factor variances/covariance between groups; if it is satisfied, group comparisons of the domain means can be performed. Complete invariance holds if the factor loadings, factor variances/covariance, and error variances are equivalent for the groups [28].

To evaluate and compare these models, the chi-squared model test (χ2/df) and chi-square difference test (Δχ2) [29] were conducted. To test model fit, we used the following fit indices: the goodness of fit index (GFI), the adjusted goodness of fit index (AGFI), the comparative fit index (CFI), the Akaike information criterion (AIC), and the root mean square error of approximation (RMSEA). The GFI, AGFI, and CFI range between zero (0) and unity (1), with unity meaning a perfect fit to the data. The AIC adjusts for model complexity [30], and smaller values indicate better fit [31]. An RMSEA of about 0.05 or less indicates a close fit of the model in relation to the degrees of freedom, while about 0.08 or less indicates a reasonable error of approximation. However, such cut-offs should be regarded as guidelines rather than as “golden rules” when assessing model fit [32]. The confirmatory factor analysis was performed with AMOS 22.0. The chi-square difference test [29] and the internal consistency reliability coefficient McDonald’s ω [33–36] were calculated with Microsoft Excel.

Analysis 2: one-way analysis of variance of AMI-MeT scores between the three groups

To demonstrate whether the AMI-MeT score (ten items) of cancer patients and workers are higher than are those of students, we performed a one-way analysis of variance (ANOVA with post hoc pairwise Bonferroni-adjusted comparisons) between the three groups. The statistical analysis was performed with SPSS 22.0. The effect size (η2) was also calculated with Microsoft Excel.

Study 2: correlating the subscales of the AMI-MeT with the dualistic concept of the self

To determine the convergent and divergent validity of the AMI-MeT, we examined whether it correlates with another theoretically relevant psychological scale. In this case, we referred to the concept of self-construal [23], which is typically defined as how individuals see the self in relation to others [37]. Markus and Kitayama coined the term “self-construal” in describing differences in the ways that Americans and Japanese define and make meaning of the self; they identified two types of self-construal: independent and interdependent [23]. Cross et al. reviewed the two types of self-construals, as follows:

Markus and Kitayama (1991) proposed that Europeans and Americans construe the self as fundamentally individual and separate from others, and they labeled this the independent self-construal (IndSC)…. In contrast, Markus and Kitayama (1991) pointed out that the Japanese tend to construe the self as fundamentally connected to others and defined by relationships with others, which they labeled the interdependent self-construal (InterSC). ([37] p. 143)

In later works, InterSC was proposed to consist of two components: “relational component” and “group-oriented component” [37–39]. Although Markus and Kitayama (1991) defined InterSC in terms of close relationships and important in-groups, “the connection between IndSC and individualism and between InterSC and collectivism is clear—so clear, in fact, that it can be difficult to distinguish between self-construal and individualism–collectivism” ([37] p. 143).

Given this conceptual background, we assumed that AMS (which includes items such as “I want to make the best decision for me” and “Even if several therapies are available, I want to find the one that’s preferable for me”) would be correlated with IndSC; in other words, those who fundamentally construe themselves as individuals may take a more personal interest in medical decision making. We also supposed that AMO (e.g., “It’s important to strive for advanced medical care” and “I want to be treated at a noted hospital”) would show a correlation with InterSC; that is, having a group-oriented awareness of medicine could affect the value individual respondents place on medical treatment that is based on social norms or expectations.

Participants and measure

The questionnaire was distributed to university students in the Kansai region of Japan. They were asked to complete the questionnaire after a psychology class in May 2012. The data from Study 2 was part of another questionnaire survey. Notably, some of the respondents from Study 2 could have answered the questionnaire in Study 1. To avoid analyzing the same students twice, we made sure to treat them as separate groups while handing out the questionnaire. Of the 518 students given the questionnaire, 335 filled it in completely (200 women and 135 men; mean age = 19.6; SD = 2.9); we excluded any answer sheets that contained missing data.

Motivation for medical treatment was measured using the AMI-MeT. To validate the dualistic concepts of the AMI-MeT subscales, we administered the Self-Construal Scale (SCS) [40], which is based on the concept of self-construal [23]. The SCS was translated into Japanese by Takahashi et al. [41]. Using a 7-point Likert-type scale (1 = strongly disagree to 7 = strongly agree), participants indicated their level of agreement with 12 items assessing IndSC (e.g., “I prefer to be direct and forthright when dealing with people I’ve just met,” “I enjoy being unique and different from others in many respects”) and 12 statements assessing InterSC (e.g., “It is important for me to maintain harmony within my group,” “It is important to me to respect decisions made by the group”).

Analysis 3: correlations between the subscales of the AMI-MeT and SCS

To demonstrate the convergent and divergent validity of the subscales of the AMI-MeT with the dualistic concepts of the self, we calculated the Pearson’s correlation coefficients between the AMI-MeT subscales and SCS subscales. This statistical analysis was performed with SPSS 22.0.

Results

Results from analysis 1: multi-group structural equation modeling

Descriptive statistics and correlation matrixes of the AMI-MeT items are reported in detail in Additional file 1. The results of the multi-group SEM with maximum likelihood estimation supported the two-factor structure of the AMI-MeT. The configural invariance model fit the data for both groups (CFI: .911; GFI: .929; AGFI: .886; RMSEA: .048). After testing the configural invariance model, we tested the other invariance models according to several sets of constraints. The chi-square test (χ2/df) and the chi-square difference test (Δχ2) showed that the weak invariance model was the best fit for the data (Table 2), although the items did not follow a normal distribution (Additional file 1). The fit indices also indicated that the weak invariance model was the best fit for the data (Table 2). Accordingly, we regarded the weak invariance model as the best model, and have displayed the standardized estimations of the model in Fig. 1. In the weak invariance model, the obtained ω for AMO and AMS ranged from .67–.75 and .72–.79, respectively, indicating high internal consistency. The results of the SEM and the high internal consistency reliability coefficients indicate that the two-factor model of the AMI-MeT was reliable and that the factor loadings of the AMO and AMS were common across the three groups.

Table 2 Test of measurement equivalences for Achievement Motive Index for Medical Treatment
Full size table
Fig. 1
figure 1

The standardized values in the hypothesized weak invariance model. The circles represent the latent factors of AMO and AMS, the rectangles represent measured indicators (i.e., Q1–Q5 represent AMO, and Q6–Q10 represent AMS), the lines connecting latent factors to indicators represent factor loadings, and the curve connecting the two latent factors represents covariation. The numbers provided are standardized values for the student group, the worker group (in parentheses), and the patient group [in brackets]

Full size image

Result from analysis 2: one-way analysis of variance of AMI-MeT scores between the three groups

The mean score of the AMI-MeT (ten items) was compared between the three groups. The score of workers and cancer patients were significantly higher than was that of students (F(2, 616) = 9.31, P < .01, η2 = .029; worker vs. student: P < .01; cancer patient vs. student: P < .01). The difference was also found for the mean scores of the AMO (five items); in contrast, AMS scores (five items) did not significantly differ between groups (Table 3).

Table 3 Scores of the Achievement Motive Index for Medical Treatment in Study 1
Full size table

Result from analysis 3: correlations between the subscales of the AMI-MeT and SCS

Before examining the correlations, we calculated the Cronbach’s alphas of the subscales of both the AMI-MeT and the SCS, as follows: AMS and AMO, α = .79 and .75, respectively; IndSC and InterSC, α = .69 and .74, respectively. The correlation analysis revealed that the AMS scores were more related with the IndSC scores (r = .25, P < .01) than with the InterSC scores (r = .19, P < .01), and that the AMO scores were more related with the InterSC scores (r = .30, P < .01) than with the IndSC scores (r = .14, P < .05). Because there was a high correlation between AMS and AMO (r = .64, P < .01), a partial correlation analysis was also conducted. When we controlled for AMO in investigating the relationships between AMS and IndSC and between AMS and InterSC, we found partial correlations of r = .22 (P < .01) and r = .00 (n.s.), respectively. Furthermore, when we controlled for AMS in investigating the relationships between AMO and IndSC and between AMO and InterSC, we found partial correlations of r = -.03 (n.s.) and r = .24 (P < .01), respectively.

Discussion

We examined the factorial validity and the internal consistency reliability of the AMI-MeT by confirming the two-factor model in multiple groups (Analysis 1), and examined the concurrent validity of the AMI-MeT, as it exhibited significant differences in the mean score between groups (Analysis 2). Additionally, we demonstrated the convergent and divergent validity of the subscales of the AMI-MeT using the SCS, as we believed that motivation for medical treatment would be theoretically linked with the concept of self-construal (Analysis 3).

As demonstrated in Analysis 1, the AMI-MeT has a two-factor structure (AMS and AMO). Notably, as shown in Analysis 2, the AMO scores of workers and cancer patients were significantly higher than were those of students, while the AMS scores did not differ among the groups. We expected both workers and cancer patients to recognize the need for medical treatment because they had actually come to the hospital, whereas university students might not recognize such a need—thus, the items of the AMO subscale may accurately reflect the value a respondent assigns on the basis of social norms or expectations, rather than personal interest. Accordingly, the AMO could be considered to have good concurrent validity. It must be noted that the concurrent validity of the AMS could not be discussed in the same manner as that of the AMO in this research setting, because the items of the AMS are not as reflective of visiting the hospital as are the items of the AMO.

Regarding the convergent and divergent validity of the subscales of the AMI-MeT (Analysis 3), the hypothesized strong associations (i.e., the correlations between AMS and IndSC and between AMO and InterSC, which were r = .25 and .30, respectively) were barely stronger than were those expected to be low (i.e., the correlations between AMS and InterSC and between AMO and IndSC, which were r = .19 and .14, respectively). However, given that the conceptual similarity between AMS and AMO could result in their being highly correlated (which was supported by our results; r = .64, P < .01), we also conducted a partial correlation analysis to eliminate the potential confounds. As the partial correlation analysis indicated, there were weak but significant associations between AMS and IndSC and between AMO and InterSC (.22 and .24, respectively), and no associations between AMS and InterSC and between AMO and IndSC (.00 and -.03, respectively). Thus, this partial correlation analysis while controlling for AMS and AMO supports the convergent and divergent validity of the subscales of the AMI-MeT.

With regard to the patient group, our interpretations must be carefully made; if a patient would urgently require medication and clearly express his or her interest, it would seem natural for him or her to mark the highest score on every question of the AMI-MeT. As such, at this point, it appears difficult to divide patients’ motivation into personal interest or established value based on social norms and expectations using the AMI-MeT. Additionally, AMO and AMS scores showed ceiling effects for cancer patients as well as stronger correlations in this group. An explanation for these results could be that cancer patients urgently require medication and hence have a high interest in treatment. As such, this ten-item AMI-MeT would be useful in the field of medical decision making for detecting patients with lower levels of motivation, who may require further assessment and support.

Application of the AMI-MeT in future analyses

To identify how motivation functions in this respect and investigate the qualities of actual physician–patient interaction during clinical consultation, we created the MORE-IC Project [12, 13]. In this study project, we collected both quantitative and qualitative data, including AMI-MeT scores, audio records, and field notes of participant observations of informed consent consultations for starting chemotherapy. As the results of the present study showed, the AMI-MeT can accurately distinguish patients with high and low motivations, and provides baseline data on patient motivation for our research project. In the future, the AMI-MeT will allow formal comparison of the process of informed consent consultations between patients with high and those with low motivation.

Limitations

The limitations are as follows. First, the two-factor model of the AMI-MeT is incomplete. Due to an unbalanced sample size, the results of the SEM were biased by the data from the student group. If each group were equal in sample size, several fit indexes could be changed and it is possible that the two-factor model would not have been proposed. Given that cancer patients showed higher correlations between AMS and AMO than did the other groups, the AMI-MeT could have a one-factor model. A one-factor model would not precisely contradict our results herein, because our two-factor model does not specify that the AMO and AMS subscales were independent. Thus, the factorial validity of the AMI-MeT remains to be clarified.

Second, although the results of the correlation analysis demonstrated the convergent and divergent validity of AMI-MeT subscales with the SCS subscales, the correlations between AMS and IndSC and between AMO and InterSC must be interpreted cautiously for the following two reasons. First, the Cronbach’s alphas of the IndSC and InterSC subscales seemed to be lower (α = .69 and .74, respectively) than in previous studies. Takahashi et al. (2009) reported Cronbach’s alphas of .48–.58 for the IndSC subscale and .86–.87 for the InterSC subscale [41]; overall, the inter-item reliabilities of these two subscales tend to be adequate at best (α = .73–.74 and .69–.70 on the IndSC and InterSC subscales, respectively [40]). Second, there was a conceptual mismatch between the AMO and InterSC subscales. That is, the items of the AMO subscale did not refer to the relationship with clinical professionals but to the collective awareness for medical treatment; in contrast, Markus and Kitayama defined InterSC according to relationships with others [23]. These reasons doubtlessly limit the convergent and divergent validity of AMI-MeT subscales in this research.

Finally, our results cannot generalize to all cancer patients. We limited our sample to cancer patients who were diagnosed with breast or lung cancer and who were asked to answer the AMI-MeT before their clinical consultation for starting outpatient chemotherapy in a university hospital. Because individuals’ concerns about cancer treatment likely differ depending on their possible treatment options, disease stage, or social role, further investigation is required to explore how patients’ interests vary.

Conclusion

We confirmed the validity and reliability of the two-factor model of the AMI-MeT and checked that the AMI-MeT could accurately measure motivation for medical treatment among different groups. In the future, when we investigate how shared decision making proceeds between Japanese physicians and patients or what occurs in their conversation process, the AMI-MeT will be useful tool for detecting patients with high and low motivation.

Abbreviations

AGFI:

adjusted goodness of fit index

AIC:

Akaike information criterion

AMI-MeT:

Achievement Motive Index for Medical Treatment

AMS:

self-derived achievement motivation

AMO:

achievement motivation derived from others

CFI:

comparative fit index

GFI:

goodness of fit index

IndSC:

independent self-construal

InterSC:

interdependent self-construal

RMSEA:

root mean square error of approximation

SCS:

Self-construal scale

SEM:

structural equation modeling

References

  1. Akabayashi A, Fetters MD, Elwyn TS. Family consent, communication, and advance directives for cancer disclosure: a Japanese case and discussion. J Med Ethics. 1999;25(4):296–301. doi:10.1136/jme.25.4.296.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Slingsby BT. Decision-making models in Japanese psychiatry: transitions from passive to active patterns. Soc Sci Med. 2004;59(1):83–91. doi:10.1016/j.socscimed.2003.10.006.

    Article  CAS  PubMed  Google Scholar 

  3. Ministry of Health and Welfare. FY 1992 report on socioeconomic survey of vital statistics; malignant neoplasm. Tokyo: Statistics and Information Department, Minister’s Secretariat, Japanese Ministry of Health and Welfare; 1994.

    Google Scholar 

  4. Ministry of Health and Welfare. FY 1994 report on socioeconomic survey of vital statistics; terminally-ill treatment. Tokyo: Statistics and Information Department, Minister’s Secretariat, Japanese Ministry of Health and Welfare; 1996.

    Google Scholar 

  5. Uchitomi Y, Okamura H, Minagawa H, Kugaya A, Fukue M, Kagaya A, et al. A survey of Japanese physicians’ attitudes and practice in caring for terminally ill cancer patients. Psychiatry Clin Neurosci. 1995;49(1):53–7. doi:10.1111/j.1440-1819.1995.tb01857.x.

    Article  CAS  PubMed  Google Scholar 

  6. Uchitomi Y. Psycho-oncology in Japan: history, current problems and future aspect. Jpn J Clin Oncol. 1999;29(9):411–2.

    Article  CAS  PubMed  Google Scholar 

  7. Matsushima E, Noguchi W, Matsushita T, Kobayashi M. A survey of “death with dignity” in Japan. Tokyo: Ministry of Health, Labour and Welfare; 2005.

    Google Scholar 

  8. Ministry of Health, Labour and Welfare. Basic plan to promote cancer control programs. 2007.

    Google Scholar 

  9. Fujimori M, Akechi T, Morita T, Inagaki M, Akizuki N, Sakano Y, et al. Preferences of cancer patients regarding the disclosure of bad news. Psychooncology. 2007;16(6):573–81. doi:10.1002/pon.1093.

    Article  PubMed  Google Scholar 

  10. Fujimori M, Parker PA, Tatsuo A, Sakano Y, Baile WF, Uchitomi Y. Japanese cancer patients’ communication style preferences when receiving bad news. Psychooncology. 2007;16(7):617–25. doi:10.1002/pon.1102.

    Article  PubMed  Google Scholar 

  11. Fujimori M, Uchitomi Y. Preferences of cancer patients regarding communication of bad news: a systematic literature review. Jpn J Clin Oncol. 2009;39(4):201–16. doi:10.1093/jjco/hyn159.

    Article  PubMed  Google Scholar 

  12. MORE-IC. Multi-methods observational research employing both qualitative and quantitative approach for outpatient chemotherapy IC. UMIN-CTR. 2009. https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=brows&action=brows&type=summary&recptno=R000001955&language=E. Accessed 10 Feb 2016.

  13. MORE-IC. Longitudinal study for observing the process of informed consent for outpatient chemotherapy. UMIN-CTR. 2012. https://upload.umin.ac.jp/cgi-openbin/ctr/ctr.cgi?function=brows&action=brows&type=summary&recptno=R000008955&language=E. Accessed 10 Feb 2016.

  14. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179–211. doi:10.1016/0749-5978(91)90020-T.

    Article  Google Scholar 

  15. Horino M. Analysis and reconsideration of the concept of achievement motive. Jpn J Educ Psychol. 1987;35(2):148–54.

    Article  Google Scholar 

  16. Maslow AH. Motivation and personality. New York: HarperCollins Publishers; 1954.

    Google Scholar 

  17. Murray HA. Explorations in personality. New York: Oxford University Press; 1938.

    Google Scholar 

  18. McClelland DC, Atkinson JW, Clark RA. The achievement motive. New York: Appleton; 1953.

    Book  Google Scholar 

  19. Yanagida K. Gann Gojyuuninn-no-Yuuki [50 cancer patients’ narratives; living a full life]. Bungei-Syunjyuu: Tokyo; 1981.

    Google Scholar 

  20. Yanagida K. Shin Gann Gojyuuninn-no-Yuuki [50 cancer patients’ narratives; Living a full life (additional version)]. Tokyo: Bungei-Syunjyuu; 2009.

    Google Scholar 

  21. Bingley AF, McDermott E, Thomas C, Payne S, Seymour JE, Clark D. Making sense of dying: a review of narratives written since 1950 by people facing death from cancer and other diseases. Palliat Med. 2006;20(3):183–95. doi:10.1191/0269216306pm1136oa.

    Article  CAS  PubMed  Google Scholar 

  22. Jung CG. Collected works of C.G. Jung. Princeton, NJ: Princeton University Press; 1971.

    Google Scholar 

  23. Markus HR, Kitayama S. Culture and the self: implications for cognition, emotion, and motivation. Psychol Rev. 1991;98(2):224–53.

    Article  Google Scholar 

  24. Ryan RM, Deci EL. Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being. Am Psychol. 2000;55(1):68–78.

    Article  CAS  PubMed  Google Scholar 

  25. Hatta T, Narita K, Yanagihara K, Ishiguro H, Kishimoto N, Hayashi A, et al. Developing the questionnaire of achievement motive for medical treatment. Jpn J Psychosom Med. 2011;51(1):73–9.

    Google Scholar 

  26. Horn JL, McArdle JJ. A practical and theoretical guide to measurement invariance in aging research. Exp Aging Res. 1992;18(3-4):117–44.

    Article  CAS  PubMed  Google Scholar 

  27. Meredith W, Teresi JA. An essay on measurement and factorial invariance. Med Care. 2006;44(11):S69–77. doi:10.1097/01.mlr.0000245438.73837.89.

    Article  PubMed  Google Scholar 

  28. Vandenberg RJ, Lance CE. A review and synthesis of the measurement invariance literature: suggestions, practices, and recommendations for organizational research. Organ Res Methods. 2000;3(1):4–69.

    Article  Google Scholar 

  29. Schermelleh-Engel K, Moosbrugger H, Müller H. Evaluating the fit of structural equation models: tests of significance and descriptive goodness-of-fit measures. Meth Psychol Res Online. 2003;8(8):23–74.

    Google Scholar 

  30. Akaike H. A new look at the statistical model identification. IEEE Trans Autom Conrol. 1974;19(6):716–23. doi:10.1109/tac.1974.1100705.

    Article  Google Scholar 

  31. Hooper D, Coughlan J, Mullen M. Structural equation modelling: guidelines for determining model fit. EJBRM. 2008;6(1):53–60.

    Google Scholar 

  32. Marsh HW. In search of golden rules: comment on hypothesis-testing approaches to setting cutoff values for fit indexes and dangers in overgeneralizing Hu and Bentler’s (1999) findings. Struct Equ Model. 2004;11(3):320–41. doi:10.1207/s15328007sem1103_2.

    Article  Google Scholar 

  33. McDonald RP. Generalizability in factorable domains: domain validity and generalizability. Educ Psychol Meas. 1978;38:75–9.

    Article  Google Scholar 

  34. McDonald RP. Test theory: a unified treatment. Mahwah, New Jersey: Lawrence Erlbaum Associates, Inc.; 1999.

    Google Scholar 

  35. Raykov T, Shrout PE. Reliability of scales with general structure: point and interval estimation using a structural equation modeling approach. Struct Equ Model. 2002;9(2):195–212.

    Article  Google Scholar 

  36. Toyoda H. Covariance structure analysis (technique edition): structural equation modelling. Tokyo: Asakura Publishing Co.; 2003.

    Google Scholar 

  37. Cross SE, Hardin EE, Gercek-Swing B. The what, how, why, and where of self-construal. Pers Soc Psychol Rev. 2011;15(2):142–79.

    Article  PubMed  Google Scholar 

  38. Cross SE, Bacon PL, Morris ML. The relational-interdependent self-construal and relationships. J Pers Soc Psychol. 2000;78(4):791–808.

    Article  CAS  PubMed  Google Scholar 

  39. Yuki M, Maddux WW, Brewer MB, Takemura K. Cross-cultural differences in relationship- and group-based trust. Pers Soc Psychol Bull. 2005;31(1):48–62.

    Article  PubMed  Google Scholar 

  40. Singelis TM. The measurement of independent and interdependent self-construals. Pers Soc Psychol Bull. 1994;20(5):580–91. doi:10.1177/0146167294205014.

    Article  Google Scholar 

  41. Takahashi C, Yamagishi T, Hashimoto H. Interdependent self as a form of self-presentation in response to a threat of exclusion from the group. Res Soc Psychol. 2009;25(2):113–20.

    Google Scholar 

Download references

Acknowledgements

We would like to express our heartfelt thanks to all responders. We must also give our thanks to Kazuhiro Takeda, MD, Ayako Kamachi, RN, Kazuyuki Hirao, MD, Masaya Sakamoto, PhD, Megumi Yama, PhD, and Satoko Inatsuki, PhD, for helping distribute the questionnaire, and to Hirofumi Hashimoto, PhD, and Toshio Yamagishi, PhD, for providing the Japanese version of the Self-Construal Scale. We thank Hidenori Kashihara, MPH, and Editage for providing editorial assistance. We also thank Takashi Mitamura, PhD, Misa Inoue, MA, Michio Yamamoto, PhD, and Toshiko Ito-Ihara, MD, for their constructive feedback.

Author information

Authors and Affiliations

  1. Uehiro Research Division for iPS Cell Ethics, Center for iPS Cell Research and Application (CiRA), Kyoto University, 53 Shogoin-Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan

    Taichi Hatta

  2. Clinical Innovative Medicine, Institute for Advancement of Clinical and Translational Science (iACT), Kyoto University Hospital, 54 Shogoin-Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan

    Keiichi Narita & Masayuki Yokode

  3. Department of Medical Oncology, Kansai Electric Power Hospital, 2-1-7 Fukushima, Fukushima-ku, 553-0003, Osaka, Japan

    Kazuhiro Yanagihara

  4. Department of Target Therapy Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan

    Hiroshi Ishiguro

  5. Department of Clinical Development, Kanazawa University Hospital, 13-1 Takara-machi, 920-8641, Kanazawa, Japan

    Toshinori Murayama

Authors
  1. Taichi Hatta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Keiichi Narita
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kazuhiro Yanagihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiroshi Ishiguro
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Toshinori Murayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masayuki Yokode
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Taichi Hatta.

Additional information

Competing interests

Financial support for this study was provided in part by grants from the Kyoto Cancer Society, the Pfizer Health Research Foundation, the Foundation for Promotion of Cancer Research, and JSPS KAKENHI (grant number 23790568 and 26870311). The funding agreement ensured the authors’ independence in designing the study, interpreting the data, writing, and publishing the report. The authors declare that they have no competing interests.

Authors’ contributions

TH carried out the data collection for all participants, participated in the study design, performed the statistical analysis, and drafted the manuscript. KN conceived of the study project, helped in its design and data collection, interpreted the data, and drafted the manuscript. KY helped to collect data from cancer patients and draft the manuscript. HI helped collect data from cancer patients and draft the manuscript. TM helped to coordinate the study and draft the manuscript. MY participated in the study project and helped to coordinate the study and draft the manuscript. All authors have read and approved the final manuscript.

Authors’ information

TH is a researcher for clinical ethics and research methodology and a member of the Mixed Methods International Association. KN is a clinical psychologist and a member of the International Neuropsychoanalysis Society. KY is a specialist in clinical oncology and a member of the American Society of Clinical Oncology. HI is a specialist in clinical oncology and a medical oncologist certified by the American Board of Internal Medicine. TM is a specialist in cardiovascular medicine and a Fellow of the American College of Physicians. MY is a specialist in internal medicine and a member of the American Society for Clinical Pharmacology and Therapeutics.

Additional file

Additional file 1:

The descriptive statistics and correlation matrix of the Achievement Motive Index for Medical Treatment. (PDF 59 kb)

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hatta, T., Narita, K., Yanagihara, K. et al. Measuring motivation for medical treatment: confirming the factor structure of the Achievement Motivation Index for Medical Treatment (AMI-MeT). BMC Med Inform Decis Mak 16, 22 (2016). https://doi.org/10.1186/s12911-016-0260-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12911-016-0260-0

Keywords

BMC Medical Informatics and Decision Making

ISSN: 1472-6947

Contact us